Abstract:Psoriasis is a common chronic inflammatory multisystem disease accompanied by hyperproliferation and inflammation of epidermal keratinocytes. Signal transducer and activator of transcription 3 (STAT3) is constitutively activated and plays an important role in epidermal keratinocytes of human psoriatic skin lesions. In this study, we investigated the effects of an endogenous STAT3 inhibitor, a protein inhibitor of activated STAT3 (PIAS3), on the proliferation and inflammation of psoriatic cells. The expression of PIAS3 in psoriatic tissues and healthy skin was analyzed using the Gene Expression Omnibus database and clinical samples. The human immortalized epidermal (HaCaT) cells were used to establish an in vitro psoriasis‐like cell model. 3–(4,5–dimethylthiazol–2–yl)–5–(3–carboxymethoxyphenyl)–2–(4–sulfophenyl)–2H–thethrazolium (MTS) assay was used to detect cell proliferation. Flow cytometry was used to determine apoptosis levels. Real‐time PCR, western blotting, and enzyme‐linked immunosorbent assay (ELISA) were used to detect the expression levels of related factors. Furthermore, a mouse model of imiquimod (IMQ)‐induced psoriatic dermatitis was established to verify the in vitro experimental results. The results showed that the mRNA and protein expression levels of PIAS3 were lower in psoriatic lesions than in normal tissues. PIAS3 inhibited the proliferation and promoted apoptosis of M5‐induced HaCaT cells. Simultaneously, the mRNA and protein expression levels of tumor necrosis factor–alpha (TNF‐α), interleukin–6 (IL‐6), interleukin–8 (IL‐8), and keratin 17 (K17) were significantly decreased and that of p53 was increased, thereby inhibiting the inflammatory response and promoting apoptosis. PIAS3 inhibited the transcription activity of STAT3 and noncanonical nuclear factor‐kappaB (NF‐κB). Furthermore, PIAS3 attenuated IMQ‐induced psoriasis‐like inflammation in mice. Our findings suggest that PIAS3 plays an important role in psoriasis by regulating the STAT3/NF‐κB signaling pathway and p53. The lack of PIAS3 may represent a novel mechanism underlying the pathogenesis of psoriasis.

Level of STAT3 and Phosphorylated STAT3 in the Lesions of Psoriasis Vulgaris

Effect of STAT3 phosphorylation and p53 expression on human epidermal non melanoma cutaneous tumors]

Expression of T-bet and GATA-3 in Lesions of Patients with Psoriasis Vulgaris

Immunohistochemical Study of Vascular Endothelium Adhesion Molecules in Psoriatic and Non-psoriatic Skin

STAT3 Activation in Psoriasis and Cancers

STAT2/Caspase3 in the diagnosis and treatment of psoriasis

[Mrna Expression of Procollagen and SMADs in Lesional Skin of Progressive Systemic Sclerosis].

Overexpression of Phosphorylated-Stat3 Correlated with the Invasion and Metastasis of Cutaneous Squamous Cell Carcinoma

Expression of CD80 on Peripheral Blood T Lymphocytes in Patients with Psoriasis

Topical Treatment of Calcipotriol Decreases Expression of ICAM-3 Positive Infiltrating Leukocytes in Psoriatic Skin

Association between psoriasis and STAT3

Clinical Significance of Stat3 and Mapk Phosphorylation, and the Protein Expression of Cyclin D1 in Skin Squamous Cell Carcinoma Tissues

Signal Transducer and Activator of Transcription-3 (STAT-3) and Psoriasis

Overexpression of vascular endothelial growth factor (VEGF) receptors on keratinocytes in psoriasis: regulated by calcium independent of VEGF.

The Significance of STAT3 and MAPK Phosphorylation and Cyclind1 Protein Expression in Skin Squamous Cell Carcinoma

Immunohistochemical study of psoriatic plaques and perilesional skin in psoriasis vulgaris patients: A pilot study

OAS1, OAS2, and OAS3 Contribute to Epidermal Keratinocyte Proliferation by Regulating Cell Cycle and Augmenting IFN-1‒Induced Jak1‒Signal Transducer and Activator of Transcription 1 Phosphorylation in Psoriasis.

The Expression of Chemokine Receptors on Neutrophils in Patients with Psoriasis Vulgaris

Serum Expression of IL-33 and ST2 in Patients with Psoriasis Vulgaris

Protein inhibitor of activated STAT3 (PIAS3) attenuates psoriasis and associated inflammation

The expression and significance of TRPV1 receptor in psoriatic lesions